Learn the step-by-step process to generate $100K building websites for realtors! This video breaks down everything from ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to ...

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...

The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to reports from The Walt Disney Company and Alibaba . So far, ...

Key Data Highlighting Vidofludimus Calcium's Therapeutic Potential in Multiple Sclerosis Presented at 41st Congress of ECTRIMS  – – Phase 2 CALLIPER ...

In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

According to a State Department cable obtained by your hosts, a senior German official recently pressed a top U.S. diplomat ...